The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. C4 Therapeutics Inc’s current trading price is -61.70% away from its 52-week high, while its distance from the 52-week low is 329.25%. The stock’s price range for this period has been between $1.06 and $11.88 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.03 million for the day, a number notably higher than the average daily volume of 1.02 million over the last three months.
In terms of market performance, C4 Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $11.88 on 03/04/24, and the lowest value was recorded at $1.06 on 12/06/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
C4 Therapeutics Inc (CCCC) has experienced a quarterly decline of -29.24% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 321.18M and boasts a workforce of 145 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.86, with a change in price of -0.45. Similarly, C4 Therapeutics Inc recorded 1,126,860 in trading volume during the last 100 days, posting a change of -9.00%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CCCC stands at 0.28. Similarly, the long-term debt-to-equity ratio is also 0.25.
CCCC Stock Stochastic Average
C4 Therapeutics Inc’s raw stochastic average for the past 50 days is presently 21.52%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 26.49%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 19.90% and 16.67%, respectively.
CCCC Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -19.47% this year. Over the last six months, there has been a stronger performance of -8.63%. The price of CCCC leaped by -22.88% during the last 30 days period. For the last 5-days stocks have improved 12.35%.
